Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: February 18, 2025
Boston Scientific Corporation
By:
/s/ Daniel J. Brennan
Daniel J. Brennan
Executive Vice President and Chief Financial Officer
(duly authorized officer and principal financial officer)
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Dated: February 18, 2025
By:
/s/ Daniel J. Brennan
Daniel J. Brennan
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
Dated: February 18, 2025
By:
/s/ Michael F. Mahoney
Michael F. Mahoney
Director, Chairman of the Board, President and Chief Executive Officer
(Principal Executive Officer)
Dated: February 18, 2025
By:
/s/ Emily M. Woodworth
Emily M. Woodworth
Senior Vice President, Global Controller and Chief Accounting Officer
(Principal Accounting Officer)
Dated: February 18, 2025
By:
/s/ Charles J. Dockendorff
Charles J. Dockendorff
Director
Dated: February 18, 2025
By:
/s/ Yoshiaki Fujimori
Yoshiaki Fujimori
Director
Dated: February 18, 2025
By:
/s/ David Habiger
David Habiger
Director
Dated: February 18, 2025
By:
/s/ Edward J. Ludwig
Edward J. Ludwig
Director
Dated: February 18, 2025
By:
/s/ Jessica L. Mega
Jessica L. Mega
Director
Dated: February 18, 2025
By:
/s/ Susan E. Morano
Susan E. Morano
Director
Dated: February 18, 2025
By:
/s/ Cheryl Pegus
Cheryl Pegus
Director
Dated: February 18, 2025
By:
/s/ John E. Sununu
John E. Sununu
Director
Dated: February 18, 2025
By:
/s/ David S. Wichmann
David S. Wichmann
Director
Dated: February 18, 2025
By:
/s/ Ellen M. Zane
Ellen M. Zane
Director
Schedule II
VALUATION AND QUALIFYING ACCOUNTS
Description(in millions)
Balance at Beginning of Year
Credit loss exposure**(1)**
Write-offs**(2)**
Balance at End of Year
Year Ended December 31, 2024:
Allowances for credit losses
$
110
41
(43)
$
109
Year Ended December 31, 2023:
Allowances for credit losses
$
109
50
(48)
$
110
Year Ended December 31, 2022:
Allowances for credit losses
$
108
35
(35)
$
109
(1) We record credit loss reserves to Allowance for credit losses when we establish Trade accounts receivable if credit losses are expected over the asset's contractual life. Subsequent credit loss reserves are recorded when deemed uncollectible. Amounts shown within credit loss exposure above were established through selling, general and administrative expense.
(2) Represents actual write-offs of uncollectible accounts.
filings.tools